r1507, an anti-insulin-like growth factor-1 receptor (igf-1r) antibody, and ewsfli-1 sirna in ewings sarcoma convergence at the igfigfrakt axisr1507,anti-insulin-like生长因子- 1受体(igf-1r)抗体,在尤文氏肉瘤融合和ewsfli-1 sirna igfigfrakt轴.pdfVIP

r1507, an anti-insulin-like growth factor-1 receptor (igf-1r) antibody, and ewsfli-1 sirna in ewings sarcoma convergence at the igfigfrakt axisr1507,anti-insulin-like生长因子- 1受体(igf-1r)抗体,在尤文氏肉瘤融合和ewsfli-1 sirna igfigfrakt轴.pdf

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
r1507, an anti-insulin-like growth factor-1 receptor (igf-1r) antibody, and ewsfli-1 sirna in ewings sarcoma convergence at the igfigfrakt axisr1507,anti-insulin-like生长因子- 1受体(igf-1r)抗体,在尤文氏肉瘤融合和ewsfli-1 sirna igfigfrakt轴

R1507, an Anti-Insulin-Like Growth Factor-1 Receptor (IGF-1R) Antibody, and EWS/FLI-1 siRNA in Ewing’s Sarcoma: Convergence at the IGF/IGFR/Akt Axis 1. 1. 1,2 1 3 Helen J. Huang , Laura S. Angelo , Jordi Rodon , Michael Sun , Klaus-Peter Kuenkele , Henrique A. 1 4 1 Parsons , Jonathan C. Trent , Razelle Kurzrock * 1 Phase I Program, Department of Investigational Cancer Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America, 2 Servei d’Oncologia Medica, Vall d’Hebron Institute of Oncology, Hospital Universitari Vall d’Hebron, Barcelona, Spain, 3 Roche Diagnostics GmbH, Penzberg, Germany, 4 Division of Cancer Medicine, Department of Sarcoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America Abstract A subset of patients with Ewing’s sarcoma responds to anti-insulin-like growth factor-1 receptor (IGF-1R) antibodies. Mechanisms of sensitivity and resistance are unknown. We investigated whether an anti-IGF-1R antibody acts via a pathway that could also be suppressed by small interfering (si) RNA against the EWS/FLI-1 fusion protein, the hallmark of Ewing’s sarcoma. The growth of two Ewing’s sarcoma cell lines (TC-32 and TC-71) was inhibited by the fully human anti-IGF-1R antibody, R1507 (clonogenic and MTT assays). TC-32 and TC-71 cells express high levels of IGF-2, while RD-ES and A4573 Ewing’s cell lines, which were less responsive to R1507 in our assays, express low or undetectable IGF-2, respectively. TC-71 cells also expressed high levels of IGF-1R, and R1507 decreased steady-state levels of this receptor by internalizati

您可能关注的文档

文档评论(0)

xyz118 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档